Bacterial And Viral Specimen Collection Market, By Product Type (Bacterial Specimen Collection and Viral Specimen Collection), By Application (Diagnostics and Research), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic and Research Institution, Others)

Published In : Feb 2025

Code : CMI4753

Pages :228

Formats :

Excel and PDF

Industry : Medical Devices

Bacterial And Viral Specimen Collection Market Size and Trends

Global bacterial & viral specimen collection market is estimated to be valued at USD 22.53 Bn in 2025 and is expected to reach USD 54.71 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032. Factors like increasing prevalence of infectious diseases, growing awareness regarding specimen collection techniques, and rapidly improving healthcare infrastructure and services across geographies can drive the market growth.

Bacterial And Viral Specimen Collection Market Key Factors

To learn more about this report, Request sample copy

Growing prevalence of infectious diseases

Rising prevalence of infectious diseases can drive the market growth. Various factors such as climate change, increased global travel and connectivity, rising antimicrobial resistance, aging population, and environmental degradation contribute to prevalence of infectious disease. As per the WHO, infectious diseases account for nearly 15 million deaths each year worldwide. There has been increase in incidences of many viral and bacterial illnesses that can have serious health and economic implications such as tuberculosis, influenza, hepatitis, HIV/AIDS, pneumonia and several vector-borne diseases.

With growing international travel and migration, diseases are also spreading across borders much rapidly than before. Outbreaks that may have remained contained locally in the past can now turn into global epidemics within weeks. This presents serious public health challenges. Overuse and misuse of antimicrobial drugs has led to many microbes developing resistance to available treatments. Drug-resistant infectious pathogens have emerged as one of the biggest threats facing humanity. All these factors reinforce the need for better infectious diseases surveillance, early detection, and prompt diagnosis worldwide. Rising population susceptibility due to factors such as aging, greater prevalence of chronic diseases and immunosuppression has also contributed to the higher infectious diseases burden. The elderly people and people with compromised immunity are at an elevated risk of infections. This underscores the importance of diligent specimen collection, targeted screening, and timely administration of appropriate treatments.